Money and Medicine The big pain point for employers is with their pharmaceutical contracts, especially given the explosive growth in new specialty drugs. (Photo: Shutterstock)

The more things change, the more they really do stay the same, to which any organization trying to effectively manage employee benefits in an unceasingly volatile environment will attest.

On one side, we continue to see health benefit costs on an unrelenting rise. More claims are trending from high to jumbo. Then, too are the near-miraculous, life-saving cures through gene therapy and specialty drugs with price tags that are out of reach for most who need them—and a worrisome burden for employers.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.